Sonderangebot Stämpflis juristische Lehrbücher: Bis Ende November profitieren Sie von 20% Rabatt auf folgende Lehr- und Praxisbücher.
Fokusthemen
Publikationen
Services
Autorinnen/Autoren
Verlag
Shop
LEXIA
Zeitschriften
SachbuchLOKISemaphor

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Herausgegeben von:Asati, Vivek|Vaidya, Ankur

Inhalt

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy discusses recently developed treatments based on molecular targets which are genetically altered in cancer cells and are essential for tumor development and survival. Considerable research effort has been devoted to the development of targeted drugs that inhibit the action of pathogenic kinases, and clinical studies performed so far have validated the positive effects of kinase inhibitors for cancer treatment. Each chapter discusses a molecular target, such as ALK2, ATR, CK, Src-Abl, EGFR, Fyn-Blk-Lyn, IGFs, and PAK1. The book's chapters are written by experts who actively work on the targets to help readers fully understand how they can be used. This is a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of novel cancer therapies based on molecular targets.

Bibliografische Angaben

April 2024, Englisch
Elsevier
978-0-323-96121-9

Inhaltsverzeichnis

Schlagworte

Weitere Titel zum Thema